Picture of Prestige Consumer Healthcare logo

PBH — Prestige Consumer Healthcare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Prestige Consumer Healthcare Q4 revenue and adjusted EPS miss estimates

Overview

US consumer healthcare firm's Q4 revenue fell 5% yr/yr, missing analyst expectations

Adjusted EPS for Q4 missed analyst expectations

Company to acquire LaCorium Health, an Australian therapeutic skin care company

Outlook

Company sees fiscal 2027 revenue of $1.1 bln to $1.121 bln

Prestige expects fiscal 2027 organic revenue growth of 1% to 3%

Company forecasts fiscal 2027 adjusted diluted EPS of $4.42 to $4.51

Result Drivers

EYE & EAR CARE SUPPLY CONSTRAINTS - Co said lower Eye & Ear Care category sales, driven by limited ability to supply demand for Clear Eyes, weighed on Q4 revenue

SHIPPING DISRUPTIONS - Q4 international segment revenue was hurt by shipping disruptions in the Middle East

PRIOR YEAR ORDER TIMING - Accelerated order timing in the prior year's Q4 created a headwind for current quarter revenue

Company press release: ID:nGNX9cCjPt

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 RevenueMiss$281.62 mln$293.66 mln (7 Analysts)
Q4 Adjusted EPSMiss$1.23$1.39 (7 Analysts)
Q4 Net Income$53.93 mln
Q4 Gross Profit$146.30 mln
Q4 Operating Expenses$70.81 mln
Q4 Operating Income$75.49 mln
Q4 Pretax Profit$64.77 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell" The average consensus recommendation for the pharmaceuticals peer group is "buy" Wall Street's median 12-month price target for Prestige Consumer Healthcare Inc is $78.00, about 54.7% above its May 12 closing price of $50.41 The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 13 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Prestige Consumer Healthcare

See all news